102 related articles for article (PubMed ID: 8330646)
1. Hemin or butyrate increases constitutive erythropoietin formation by mouse erythroleukemia cell lines.
Hermine O; Dong YJ; Beru N; Goldwasser E
Exp Hematol; 1993 Aug; 21(9):1207-11. PubMed ID: 8330646
[TBL] [Abstract][Full Text] [Related]
2. Production of erythropoietin by cloned malignant murine erythroid cells.
Choppin J; Casadevall N; Lacombe C; Wendling F; Goldwasser E; Berger R; Tambourin P; Varet B
Exp Hematol; 1985 Aug; 13(7):610-5. PubMed ID: 3861324
[TBL] [Abstract][Full Text] [Related]
3. Identification of the erythropoietin receptors of erythroleukemic cells.
Wang FF; Wang YJ; Lee HJ; Fong JC
Biochem Int; 1989 Jan; 18(1):163-71. PubMed ID: 2541719
[TBL] [Abstract][Full Text] [Related]
4. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
[TBL] [Abstract][Full Text] [Related]
5. Abnormal erythropoietin (Epo) gene expression in the murine erythroleukemia IW32 cells results from a rearrangement between the G-protein beta2 subunit gene and the Epo gene.
Chrétien S; Duprez V; Maouche L; Gisselbrecht S; Mayeux P; Lacombe C
Oncogene; 1997 Oct; 15(16):1995-9. PubMed ID: 9365246
[TBL] [Abstract][Full Text] [Related]
6. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
Chen YL; Wu RT
Cancer Res; 1994 Apr; 54(8):2192-8. PubMed ID: 7513611
[TBL] [Abstract][Full Text] [Related]
7. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity.
Howard JC; Berger L; Bani MR; Hawley RG; Ben-David Y
Oncogene; 1996 Apr; 12(7):1405-15. PubMed ID: 8622856
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
9. Induction by hemin of proliferation and of differentiation of progenitor erythroid cells responsible for erythropoietin.
Mayeux P; Felix JM; Billat C; Jacquot R
Exp Hematol; 1986 Oct; 14(9):801-8. PubMed ID: 3758232
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin-dependent suppression of the expression of the beta subunits of the interleukin-3 receptor during erythroid differentiation.
Carta C; Campisi S; Migliaccio G; Migliaccio AR
Blood Cells Mol Dis; 2000 Oct; 26(5):467-78. PubMed ID: 11112384
[TBL] [Abstract][Full Text] [Related]
11. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
Lin TS; Ishiguro K; Sartorelli AC
Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
13. Can glutathione-S-transferases function as intracellular heme carriers?
Kirschner-Zilber I; Laufer H; Shaklai N
J Cell Biochem; 1989 Nov; 41(3):113-23. PubMed ID: 2613748
[TBL] [Abstract][Full Text] [Related]
14. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-myc proto-oncogene during podophyllotoxin induced IW32 erythroleukemia cell differentiation.
Yen YT; Wu RT; Tang SJ; Wang FF
Biochem Biophys Res Commun; 1991 Sep; 179(3):1241-6. PubMed ID: 1930169
[TBL] [Abstract][Full Text] [Related]
16. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
17. Induced megakaryocytic maturation of the human leukemia cell line UT-7 results in down-modulation of erythropoietin receptor gene expression.
Komatsu N; Fujita H
Cancer Res; 1993 Mar; 53(5):1156-61. PubMed ID: 8439961
[TBL] [Abstract][Full Text] [Related]
18. Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitro.
Mitjavila MT; Le Couedic JP; Casadevall N; Navarro S; Villeval JL; Dubart A; Vainchenker W
J Clin Invest; 1991 Sep; 88(3):789-97. PubMed ID: 1653276
[TBL] [Abstract][Full Text] [Related]
19. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
20. Studies of the constitutive expression of the mouse erythropoietin gene.
Beru N; McDonald J; Goldwasser E
Ann N Y Acad Sci; 1989; 554():29-35. PubMed ID: 2735652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
